Literature DB >> 12234862

Carbapenem-resistant Pseudomonas aeruginosa in malaysia producing IMP-7 beta-lactamase.

Siaw Eng Ho1, Geetha Subramaniam, Selvi Palasubramaniam, Parasakthi Navaratnam.   

Abstract

We have isolated and identified a carbapenem-resistant Pseudomonas aeruginosa strain from Malaysia that produces an IMP-7 metallo-beta-lactamase. This isolate showed high-level resistance to meropenem and imipenem, the MICs of which were 256 and 128 micro g/ml, respectively. Isoelectric focusing analyses revealed pI values of >9.0, 8.2, and 7.8, which indicated the possible presence of IMP and OXA. DNA sequencing confirmed the identity of the IMP-7 determinant.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12234862      PMCID： PMC128803          DOI： 10.1128/AAC.46.10.3286-3287.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  11 in total

1.  Plasmid-encoded metallo-beta-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem.

Authors:  H Yano; A Kuga; R Okamoto; H Kitasato; T Kobayashi; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae.

Authors:  J J Yan; W C Ko; J J Wu
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

3.  Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7).

Authors:  Alan Patrick Gibb; Chanwit Tribuddharat; Richard A Moore; Thomas J Louie; Wally Krulicki; David M Livermore; Marie-France I Palepou; Neil Woodford
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Carbapenemase-producing Pseudomonas aeruginosa in UK.

Authors:  N Woodford; M F Palepou; G S Babini; J Bates; D M Livermore
Journal:  Lancet       Date:  1998-08-15       Impact factor: 79.321

5.  Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended-spectrum beta-lactamase to other members of the family enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; J Lopez; A Pechinot; A Kazmierczak
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Convenient test for screening metallo-beta-lactamase-producing gram-negative bacteria by using thiol compounds.

Authors:  Y Arakawa; N Shibata; K Shibayama; H Kurokawa; T Yagi; H Fujiwara; M Goto
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Rapid procedure for detection and isolation of large and small plasmids.

Authors:  C I Kado; S T Liu
Journal:  J Bacteriol       Date:  1981-03       Impact factor: 3.490

8.  IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998.

Authors:  Y W Chu; M Afzal-Shah; E T Houang; M I Palepou; D J Lyon; N Woodford; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

9.  Structure of In31, a blaIMP-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes.

Authors:  N Laraki; M Galleni; I Thamm; M L Riccio; G Amicosante; J M Frère; G M Rossolini
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

10.  PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams.

Authors:  K Senda; Y Arakawa; S Ichiyama; K Nakashima; H Ito; S Ohsuka; K Shimokata; N Kato; M Ohta
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948
View more
  8 in total

1.  Regional spread of Pseudomonas aeruginosa ST357 producing IMP-7 metallo-β-lactamase in Central Europe.

Authors:  Jaroslav Hrabák; Dana Cervená; Radoslaw Izdebski; Wojciech Duljasz; Marek Gniadkowski; Marta Fridrichová; Pavla Urbásková; Helena Zemlicková
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

2.  Clonal spread of IMP-1-producing Pseudomonas aeruginosa in two hospitals in Singapore.

Authors:  Tse Hsien Koh; Grace Chee Yeng Wang; Li-Hwei Sng
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 3.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  IMP-43 and IMP-44 metallo-β-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa.

Authors:  Tatsuya Tada; Tohru Miyoshi-Akiyama; Kayo Shimada; Masahiro Shimojima; Teruo Kirikae
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

5.  IMP-12, a new plasmid-encoded metallo-beta-lactamase from a Pseudomonas putida clinical isolate.

Authors:  Jean-Denis Docquier; Maria Letizia Riccio; Claudia Mugnaioli; Francesco Luzzaro; Andrea Endimiani; Antonio Toniolo; Gianfranco Amicosante; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 6.  Epidemiology and Characteristics of Metallo-β-Lactamase-Producing Pseudomonas aeruginosa.

Authors:  Duck Jin Hong; Il Kwon Bae; In-Ho Jang; Seok Hoon Jeong; Hyun-Kyung Kang; Kyungwon Lee
Journal:  Infect Chemother       Date:  2015-06-30

7.  Draft Genome Sequence of an IMP-7-Producing Pseudomonas aeruginosa Bloodstream Infection Isolate from Australia.

Authors:  K L McCarthy; A Jennison; A M Wailan; D L Paterson
Journal:  Genome Announc       Date:  2017-07-06

8.  Genetic mechanisms and correlated risk factors of antimicrobial-resistant ESKAPEE pathogens isolated in a tertiary hospital in Malaysia.

Authors:  Soo Tein Ngoi; Chun Wie Chong; Sasheela Sri La Sri Ponnampalavanar; Soo Nee Tang; Nuryana Idris; Kartini Abdul Jabar; Michael J Gregory; Tupur Husain; Cindy Shuan Ju Teh
Journal:  Antimicrob Resist Infect Control       Date:  2021-04-23       Impact factor: 4.887
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.